 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Agamree® | VBP-15 | VBP15
                                 vamorolone is an approved drug (FDA & EMA (2023)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Vamorolone (VBP15) is a novel, oral non-hormonal steroid modulator, that was investigated in Duchenne muscular dystrophy. It is a multi-functional drug that exhibits anti-inflammatory, membrane stabilisation, and mineralocorticoid receptor antagonist activities. Vamorolone was proposed as a potential replacement for the corticosteroids that are currently used in DMD, as it appears to cause fewer of the common corticosteroid adverse effects [4].
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Immunopharmacology Comments | 
| VBP15 selectively engages the GR, exerting anti-inflammatory and membrane stabilising effects [1]. |